GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 Notes to the Consolidated Financial Statements for the year ended March 31, 2022 222 ( ` in lakhs ) Gross Carrying Value Accumulated Amortisation Net Carrying Value As at April 1, 2020 Additions Disposals Assets held for Sale (Refer Note 3(b) above) As at March 31, 2021 As at April 1, 2020 Charge for the year On Disposals On Assets held for Sale (Refer Note 3(b) above) As at March 31, 2021 As at March 31, 2021 Intangible Assets Computer Software 94,46.48 2,77.24 - 23,79.43 73,44.29 44,83.97 9,03.35 - 23,79.43 30,07.89 43,36.40 Total 94,46.48 2,77.24 - 23,79.43 73,44.29 44,83.97 9,03.35 - 23,79.43 30,07.89 43,36.40 Note 6 : Non-current financial assets - Loans ( ` in lakhs ) As at March 31, 2022 As at March 31, 2021 Unsecured considered doubtful 26.55 26.55 Less: Allowance for doubtful deposits (26.55) (26.55) Loans to related parties - Unsecured considered good 190,00.00 - 190,00.00 - Note 7 : Non-current financial assets - Others ( ` in lakhs ) As at March 31, 2022 As at March 31, 2021 Margin money / Deposit against bank guarantee 4,10.78 4,01.47 Security Deposits - Unsecured considered good 6,94.06 8,06.08 Security Deposits - Unsecured considered doubtful 2,57.06 2,57.71 Less: Allowance for doubtful deposits (2,57.06) (2,57.71) Term deposit with maturity period of more than twelve months 1.45 1.45 11,06.29 12,09.00 Note 8 : Other non-current assets ( ` in lakhs ) As at March 31, 2022 As at March 31, 2021 Capital advances 3,13.23 2,87.24 Less : Allowance for doubtful advances (2,83.17) (2,83.17) 30.06 4.07 Balances with Government Authorities 19,16.60 15,86.97 Sundry Deposits 31,48.18 31,23.66 Others 1,33.18 3,02.02 52,28.02 50,16.72